BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, November 24, 2024
See today's BioWorld Asia
Home
» Roche’s Columvi and GSK’s Blenrep among 23 phase III successes in June
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Biopharma clinical updates June 2024
Roche’s Columvi and GSK’s Blenrep among 23 phase III successes in June
July 30, 2024
By
Amanda Lanier
No Comments
In June 2024,
BioWorld
covered 221 clinical trial updates, compared to 298 in May.
BioWorld
recorded 23 phase III trial successes in June, seven failures, and one with mixed results.
BioWorld Asia
Analysis and data insight
Clinical
FDA
